Skip to main content
PAINWeek 2023 Main banner
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it

Full Schedule

  1. Home
  2. Full Schedule
Sort by Full Schedule      Sort by Title      Sort by Track      Sort by Faculty  

Full Schedule

  • Cancelled
  • A Brief Case Report on Umbilical Cord Connective Tissue Allograft Application for Achilles Tendonitis
  • A Retrospective Evaluation of Over-the-Counter Products Versus Recently Approved Oral Prescription Products for Episodic Migraine
  • ADV502: Possible Role for Maintenance treatment of (Poly)Substance Use Disorder
  • Alexander Technique as a Pain Self-Management Tool in Hypermobility Syndromes
  • Assessment of the Potential for Drug–Drug Interactions Between INP104 (Trudhesa®) and Gepants for Migraine Management Using a Model-based Approach
  • Association between per capita prescribing and abuse of tapentadol and other opioids among individuals entering treatment for opioid use disorders
  • At-Home Virtual Reality Program for Chronic Low Back Pain: A Randomized Controlled Trial in a Clinically Severe and Demographically Diverse Sample
  • Attitude of Providers Towards Long-Term Opioid Use for Chronic Pain.
  • Brachioradial Pruritus: An Etiological Review and Treatment Summary
  • Burden of illness of opioid-induced constipation among commercially insured patients with cancer in the United States
  • Changes in oxycodone misuse and abuse trends across COVID-19: A look back
  • Characterization of the NLRP3 Inflammasome Inhibitor HT-6184 in the Complete Freund's Adjuvant (CFA)-Induced Pain Model
  • Comparison of efficacy of topical diclofenac sodium 1% gel and acetaminophen extended-release for treatment of symptomatic knee osteoarthritis
  • Decreased Healthcare Resource Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch : A Retrospective Claims Analysis
  • Depression in opioid-dependent chronic pain patients in rural Texas: a complex relationship
  • Developing a Comprehensive Pain Management Curriculum in Physician Assistant Education
  • Differences in the severity of medical outcomes of exposures reported to poison centers involving XTAMPZA® ER and other opioid analgesics
  • Dronabinol useful for chronic pain: a case report
  • Economic burden of opioid-induced constipation: An analysis of commercially insured patients without cancer in the United States
  • Effect of acupuncture for pain management in patients with Temporomandibular disorders: A Systematic Review and Meta Analysis
  • Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial
  • Efficacy of Zavegepant Nasal Spray for the Acute Treatment of Migraine Based on Triptan Treatment Experience: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials
  • EP-104IAR (Long-Acting Intra-Articular Injection of Fluticasone Propionate): Results from a Phase 2 Randomized, Double-blind, Vehicle-Controlled Trial in 318 Subjects with Knee Osteoarthritis
  • Evaluating Components of Interdisciplinary Treatment Programs for Chronic Pain: A Scoping Review
  • Evaluating Outcomes of a Resident Driven Naloxone Distribution Initiative
  • Evaluation of Pain Management Strategies in Cesarean Delivery
  • Evaluation of the Efficacy of Cryopreserved Human Umbilical Cord Tissue Allografts to Augment Functional and Pain Outcome Measures in Patients with Knee Osteoarthritis: An Observational Data Collection Study
  • Evaluation of the Therapeutic Efficacy of Entrapment Neuropathy Unties (ENUs) Pharmacoacupuncture in Neuropathic Pain Caused by Sciatic Nerve Ligation (SNL) in Mice
  • Evolution of the Osteoarthritis Guidelines with a Focus on Over-the-Counter Treatment Options
  • Haptic Vibrotactile Trigger Technology: Disrupting the Neuromatrix to Reduce Pain Severity and Interference: Results from the HARMONI Study
  • Head and Neck Cancer-related Pain: A Descriptive Analysis of the Pain Phenotypes
  • Healthcare Cost and Resource Use in Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis
  • Healthcare Costs Associated with Rates of Prescription Opioid Misuse/Abuse
  • Impact of Adhesion on Patient Satisfaction, Medication Switching and Discontinuation With Lidocaine Topical Patches Based on FDA Adverse Event Reporting and Patient Surveys
  • Impact of Treatment with High Concentration Capsaicin (8%) Topical System on Sensory Testing in Patients Living with Painful Diabetic Peripheral Neuropathy of the feet: a Post-Hoc Analysis of the PACE Trial
  • Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial
  • Improving Patient Safety and Outcomes Through Electronic Health Record Integration of Opioid Monitoring Guidelines
  • Inequities in pain assessment and management across demographic and geriatric-related variables in older, hospitalized adults
  • Intranasal and Oral Human Abuse Potential (HAP) Studies with PF614: A Novel Trypsin Activated Abuse Protected (TAAP) Extended-Release Oxycodone Prodrug
  • Long-Term Safety of Zavegepant Nasal Spray in Patients with Migraine and Cardiovascular Risk Factors
  • Novel, Non-Addictive Opioid Dimer DMX-101 Targets Peripheral Opioid Receptors for Treatment of Chronic Pain without Risks Associated with Traditional Opioids
  • Oral herbal medicine for treatment of postherpetic neuralgia: A systematic review and meta-analysis
  • Outcomes of an Outpatient Functional Restoration Pain Program: A Comparison of Virtual and Face to Face Modalities in Veterans
  • Pain and Quality of Life metrics following Use of Repeated Ketamine Infusion in Chronic Pain Patients.
  • Perception of Stigma on Continuity of Care Among Women Living with Chronic Pain in Accra, Ghana
  • Percutaneous Electrical Nerve Stimulator for Treatment of Chronic Spinal Pain
  • Peripheral Nerve Stimulation- A Novel, Minimally Invasive Technique in Treating Painful TKRs- An Orthopedic Surgeon Perspective
  • PF614-MPAR: A Novel Trypsin Activated Abuse Protected (TAAP) Extended-Release Oxycodone Prodrug with Overdose Protection
  • Physical therapy for the treatment of Unspecific Chronic Low Back Pain: A systematic review and meta-analysis of randomized controlled trials
  • Postoperative Respiratory Depression: A Review and Call to Action
  • Psychological Interventions for Chronic Pain & Trauma Management: A Scoping Review
  • Real-world assessment of concomitant migraine medication use in patients using INP104 (Trudhesa®) in the United States
  • Real-world impact of abuse-deterrent formulation of XTAMPZA ER in the context of behaviors around tampering with XTAMPZA® ER and other opioid products
  • Reduction in barbiturate prescription fills and quantity dispensed following initiation of rimegepant treatment: A real-world administrative claims study
  • Review of Multimodal Therapies for the Treatment of Neuropathic Pain: Clinical Implications
  • Revisiting the Role of Stellate Ganglion Blocks for Management of Upper Extremity Complex Regional Pain Syndrome: A Case Study
  • Safety and Tolerability of ENA-001 for the Management of Pharmacologically-induced Respiratory Depression
  • Safety and Tolerability of Schedule III Buprenorphine and Oral Schedule II Opioid Treatment in Chronic Low Back Pain Patients: A Retrospective US Commercial Claims Analysis
  • Screening for Osteoporosis Risk in Male Patients on Long-Term Opioid Therapy
  • Shocking Incidents during Radiofrequency for Facet Joint Pain in Patients with Permanent Pacemakers and Defibrillators
  • Sigma Receptor Redux
  • Sigma-1 and Sigma-2 Chaperone-Receptors for Therapeutic Targets
  • Single Level S1 Dorsal Root Ganglion Stimulation For Painful Diabetic Peripheral Neuropathy: A Case Report
  • Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Disorder: An Investigative Case Series
  • Stellate Ganglion Block - a potential treatment for “Long-Covid 19” patients suffering with Anosmia and Ageusia: A Case Report
  • Structured mindfulness training promotes independent home practice, practice quality, and improvements in functioning in Veterans with chronic pain: Results from a pilot study
  • Sustained Risk Reduction of Severe Clinical Outcomes Following Misuse/Abuse of XTAMPZA ER as Compared to Other Prescription Opioids
  • Targeted high dose opioid reduction: A collaboration with primary care
  • The Durability and Efficiency of Cryopreserved Human Umbilical Cord Tissue Allograft for the Supplementation of Cartilage Defects Associated with the Sacroiliac Joint: A Case Series
  • The Effectiveness and Safety of Acupuncture for Shoulder Impingement Syndrome: A Systematic Review and Meta-analysis.
  • The effectiveness of a novel Audio-Visual-Stimulation Device for improving symptoms and quality of life in fibromyalgia; a fully remote large-scale trial
  • The Mechanism of Action of a Novel Respiratory Stimulant
  • The Need for an Agnostic Pharmacologic Approach to Polysubstance Overdose
  • The Prevalence of Mental Health Diagnoses and Biopsychosocial Treatment Plans During Opioid Tapering at a Rural Appalachian VA
  • The Societal Impact of Prescription Opioid Use and Opioid Use Disorder and in the United States: A Current Perspective (2016–2023)
  • Three-Dimensional Electron Microscopy of Human Umbilical Cord Tissue Allograft Pre and Post Processing: A Literature Comparison
  • Treatment Characteristics of Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis
  • Ubrogepant for the Acute Treatment of Migraine When Administered During the Prodrome (Premonitory Phase): Results From a Phase 3, Randomized, Double-blind, Placebo-Controlled, Crossover Study
  • Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of XTAMPZA ER on Opioid Tampering in a Post-Market Setting
  • Veterans in a residential functional restoration program for chronic pain demonstrate improvements in sleep symptoms with and without CBT-I enrollment
  • What’s Next on the Drug Abuse Landscape: Development of Laboratory Testing for Novel Psychoactive Substances (NPS)